🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study

Recruitingn/aAges 60 Years - 85 YearsAllManuel Montero Odasso
NCT03020381 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Motor slowing and cognitive slowing are more prevalent as we age. Importantly, the presence of both in an older person increases their risk of having dementia by ten times. Currently, there are no clinically meaningful predictors of progression to dementia in people with mild cognitive impairment (MCI). The main hypothesis is that subtle variations in gait while performing a simple cognitive task is a reliable, easy to perform, and feasible methodology to detect those older adults at higher risk of progression to dementia and also, at higher risk of further mobility decline and falls. Rationale. The Canadian population is aging. According to recent estimates, the proportion of the population aged 65 and older will increase rapidly from 13% in 2005 to 25% by 2031. This increase in proportion is accompanied by a considerable amount of disability and subsequent dependency which has major e

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
General Inclusion Criteria: * Absence of Dementia (DSM IV-TR or DSM V criteria) * Aged 60-85 years * Able to walk independently 10 meters without any gait aid (for example: walker, cane); Exclusion Criteria: * Unable to understand English; * Parkinsonism or any neurological disorder with residual motor deficit (e.g.: stroke, epilepsy); * Musculoskeletal disorder detected by clinical examination which affects gait performance; * Active osteoarthritis affecting the lower limbs at clinical evaluation * Use of psychotropics which can affect motor performance (e.g. neuroleptics and benzodiazepines) * Severe Depression (score \> 12/15 on the Geriatric Depression Scale).
💊

What it tests

  • Not listed
📍

Where

1 site
Gait and Brain Lab, Parkwood Institute
London, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy